<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39420307</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence and exploratory factor analysis of long COVID-19 symptoms among experienced infected population in Bangkok, Thailand.</ArticleTitle><Pagination><StartPage>2863</StartPage><MedlinePgn>2863</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2863</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20275-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with long COVID may experience various concomitant symptoms caused by inflammation, which affect their lives and well-being. In this study, we aimed to (1) investigate the prevalence of long COVID; (2) explore the levels of symptom severity and functional disability owing to long COVID, overall health, and their relationship; and (3) conduct exploratory factor analysis of long COVID-19 symptoms among experienced infected population in the capital of Thailand.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional research design was used and a sample of 337 community members with previously COVID-19 infection in Bangkok, Thailand was recruited for this study. Purposive sampling was used. Data collection was performed using an online and a paper-based questionnaire. Descriptive statistics (number, percentage), odds ratio, exploratory factor analysis, and Spearman's rank correlation coefficient were used for the data analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of long COVID was 32.9%. The main reported symptoms included anxiety (28.5%), fatigue (26.1%), and dyspnea (13.4%). There was a significant relationship between symptom severity and functional disability (r<sub>s</sub>=0.385, p value&#x2009;&lt;&#x2009;0.01). Overall health was negatively correlated with symptom severity (r<sub>s</sub>&#x2009;=&#x2009;-&#x2009;0.291, p&#x2009;&lt;&#x2009;.01) and functional disability (r<sub>s</sub>&#x2009;=&#x2009;-&#x2009;0.108, p&#x2009;&lt;&#x2009;.05). Using principal component analysis with Promax rotation, three clusters were identified, explaining 71.44% of the total variance. The Clusters comprised (1) common symptoms of long COVID and communication, (2) fatigue, functioning, and nutritional concerns, and (3) psychosocial impacts.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present results might help multidisciplinary care teams understand the concurrent symptoms of patients with long COVID and develop rehabilitation care programs to ease all symptoms simultaneously and improve patients' quality of life.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krongthaeo</LastName><ForeName>Suphanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7942-7784</Identifier><AffiliationInfo><Affiliation>Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama VI Road, Phaya Thai, Ratchathewi, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Partiprajak</LastName><ForeName>Suphamas</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1601-4397</Identifier><AffiliationInfo><Affiliation>Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama VI Road, Phaya Thai, Ratchathewi, Bangkok, 10400, Thailand. suphamas.par@mahidol.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piaseu</LastName><ForeName>Noppawan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2305-8905</Identifier><AffiliationInfo><Affiliation>Ramathibodi School of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama VI Road, Phaya Thai, Ratchathewi, Bangkok, 10400, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Promotion and Well-Being, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ckumdee</LastName><ForeName>Sineenuch</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nursing Department, Faculty of Medicine Ramathibodi Hospital, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taaon</LastName><ForeName>Chonthicha</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nursing Department, Faculty of Medicine Ramathibodi Hospital, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongsuwan</LastName><ForeName>Anon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Health Promotion and Well-Being, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Functional disability</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Symptom cluster</Keyword><Keyword MajorTopicYN="N">Thailand</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>23</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39420307</ArticleId><ArticleId IdType="pmc">PMC11488197</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20275-5</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20275-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard Global 2023 [Available from: https://covid19.who.int/</Citation></Reference><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard Thailand 2023 [Available from: https://covid19.who.int/region/searo/country/th</Citation></Reference><Reference><Citation>Department of Disease Control. Ministry of Public Health, Thailand. COVID-19 situation in Thailand. [Available from: https://ddc.moph.go.th/covid19-dashboard/?dashboard=province</Citation></Reference><Reference><Citation>Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831863</ArticleId><ArticleId IdType="pubmed">33130203</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S, Harb J, Rima M, Annweiler C, Wu Y, Cao Z, et al. The pathophysiology of long COVID throughout the renin-angiotensin system. Molecules. 2022;27(2903):1&#x2013;21. 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi&#x144;ko A, Turo&#x144;-Skrzypi&#x144;ska A, Ry&#x142; A, Tomska N, Bereda Z, Rotter I. Searching for factors influencing the severity of the symptoms of long COVID. Int J Environ Res Public Health. 2022;19(8013):1&#x2013;21. 10.3390/ijerph19138013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9265986</ArticleId><ArticleId IdType="pubmed">35805671</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla AS, et al. The conundrum of long-COVID-19: a narrative review. Int J Gen Med. 2021;14:2491&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. Br Med J. 2021;372:1&#x2013;4. 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. Br Med J. 2020;371:m4938. 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4). 10.1016/j.cmi.2021.11.002. 611. e9-611. e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA. (2022). Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy and Asthma Proceedings, 43(3), 187 &#x2013; 93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med. 2023;10:1&#x2013;20. 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">11298204</ArticleId></ArticleIdList></Reference><Reference><Citation>Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;32:17&#x2013;21. 10.1093/jncimonographs/lgh023.</Citation><ArticleIdList><ArticleId IdType="pubmed">15263036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pumipak B, Jittimanee S, Thananun S, Mathong K, Poungdok J, Sinsap M, et al. Symptom Experience and Perceived Health Status of people with Long COVID in Thailand. SAGE Open Nurs. 2023;9:23779608231206748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10580730</ArticleId><ArticleId IdType="pubmed">37854789</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O&#x2019;Brien KK. Conceptualising long COVID as an episodic health condition. BMJ Global Health. 2021;6:e007004. 10.1136/bmjgh-2021-007004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. 2005;5(2):159&#x2013;68. 10.1207/s15327574ijt0502_4.</Citation></Reference><Reference><Citation>Sivan M, Halpin S, Gee J, Makower S, Parkin A, Ross D, et al. The self-report version and digital format of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) for long covid or Post-COVID syndrome assessment and monitoring. Adv Clin Neurosci Rehabilitation. 2021;20(3):1&#x2013;5. 10.47795/QROO4168.</Citation></Reference><Reference><Citation>Sivan M, Parkin A, Makower S, Greenwood DC. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service. J Med Virol. 2022;94(4):1419&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Partiprajak S, Krongthaeo S, Piaseu N, Wongsathikun J, Kongsuwan A. The Thai version of the COVID-19 Yorkshire Rehabilitation Scale: a valid instrument for the psychometric assessment of the community members in Bangkok, Thailand. BMC Public Health. 2023;23(663):1&#x2013;7. 10.1186/s12889-023-15566-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10088103</ArticleId><ArticleId IdType="pubmed">37041552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Preston N, Parkin A, Makower S, Gee J, Ross D, et al. The modified COVID-19 Yorkshire Rehabilitation Scale (C19&#x2010;YRSm) patient&#x2010;reported outcome measure for long covid or Post&#x2010;COVID&#x2010;19 syndrome. J Med Virol. 2022;94(9):4253&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Cabrera EX, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, de la Cerda MLR, et al. Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Therapeutic Adv Infect Disease. 2022;9:1&#x2013;17. 10.1177/20499361211069264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post-coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a Meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:1&#x2013;12. 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B, et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw open. 2021;4(9):1&#x2013;11. 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garcia B, Besteiro Balado Y, Perez Lopez A, Romay Lema E, March&#xe1;n-L&#xf3;pez &#xc1;, Rodr&#xed;guez &#xc1;lvarez A, et al. Assessment of post-COVID symptoms using the C19-YRS tool in a cohort of patients from the first pandemic wave in northwestern Spain. Telemedicine e-Health. 2023;29(2):278&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">35727139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4). 611.e9-611.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun M, Singh AK, Pal D, Das K, Gajjala A, Venkateshan M et al. (2022). Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19. medRxiv. 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor RJ, Preston N, Parkin A, Makower S, Ross D, Gee J, et al. The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort. J Med Virol. 2022;94(3):1027&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662016</ArticleId><ArticleId IdType="pubmed">34676578</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, de Noordhout M C., et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>